Search
-
Entertainment
Entertainment in the future is likely to be digital and increasingly virtual as multiple screens mediate nearly all aspects of our lives. Ipsos envisions what this new reality will mean for creators, platforms, companies, brands and even our cars to engage audiences where they’re headed next.
-
Education
America’s education system faces multiple changes that will impact how it prepares the workforce of tomorrow. The skills that workers need are rapidly evolving. The technology to teach those skills is advancing exponentially. Ipsos asks how do we ensure that we’re aligning education for the future workforce?
-
Our Hybrid World: Technology’s Role in Supporting a Balanced Lifestyle
Hear new insights about how consumers are navigating through a hybrid existence and the role brands can play in supporting having a balanced lifestyle.
-
Ipsos Panel Reveals How to Connect with the Solitary Gen Z Viewer
Discover insights collected from our panel of Gen Z teens exploring media and entertainment consumption behaviors.
-
Insights For Pharma: Helping ‘Challenger’ Brands Win
Discover tips for how a “challenger” brand can make a mark, and ultimately win at launch...
-
Channel Performance Management
Read more about three focus areas to consider when measuring and managing channel performance.
-
Global Trends 2021: Aftershocks and continuity
Seven in ten globally now say they tend to buy brands that reflect their personal values and that business leaders have a responsibility to speak out on social issues.
-
For Mobile Wallets, Restaurant Frustrations are an Opportunity
Brands should emphasize convenience in industries that are seeing long wait times for customers, particularly at restaurants.
-
How can financial providers assist in the big wealth transfer?
Americans age 70 and older have stockpiled more than $35 trillion, which will lead to an unprecedented transfer of wealth over the coming years.
-
Oncology: the disease, dynamics & challenges of market research
The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved: patients, their carers, cancer treaters, and treatment manufactures.